Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Marijuana use & blood vessel damage | More than 2 million CGM receivers recalled | Soda, fruit juice increase diabetes risk
Thursday, June 19, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Health

Marijuana use linked to blood vessel damage—impact seen with smoking and edibles

"As cannabis legalization increases, it is crucial to understand the public health and clinical implications of marijuana use," researchers wrote in JAMA Cardiology.

READ MORE >
cannabis weed marijuana heart health doctor cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Marijuana use linked to blood vessel damage—impact seen with smoking and edibles

Share on Twitter Share on Facebook Share on Linkedin
cannabis weed marijuana heart health doctor cardiologist
"As cannabis legalization increases, it is crucial to understand the public health and clinical implications of marijuana use," researchers wrote in JAMA Cardiology.
READ MORE >

Updated: Dexcom recalls more than 700K CGM receivers over safety issues—dozens of adverse events reported

There is an increased risk that these devices will not provide audible alerts for low or high blood glucose levels. The FDA has ruled that this is a Class I recall, highlighting the safety risks associated with missed alerts.

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

Updated: Dexcom recalls more than 700K CGM receivers over safety issues—dozens of adverse events reported

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
There is an increased risk that these devices will not provide audible alerts for low or high blood glucose levels. The FDA has ruled that this is a Class I recall, highlighting the safety risks associated with missed alerts.
READ MORE >

Drinking sugar ‘more problematic’ than eating it: Soda, fruit juice linked to high diabetes risk

“Rather than condemning all added sugars, future dietary guidelines might consider the differential effects of sugar based on its source and form," one researcher said.

READ MORE >
soda soft drink coke
Share on Twitter Share on Facebook Share on Linkedin

Drinking sugar ‘more problematic’ than eating it: Soda, fruit juice linked to high diabetes risk

Share on Twitter Share on Facebook Share on Linkedin
soda soft drink coke
“Rather than condemning all added sugars, future dietary guidelines might consider the differential effects of sugar based on its source and form," one researcher said.
READ MORE >

Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’

The new name will be familiar to anyone who knows the history of Medtronic's diabetes business.

READ MORE >
business launch
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’

Share on Twitter Share on Facebook Share on Linkedin
business launch
The new name will be familiar to anyone who knows the history of Medtronic's diabetes business.
READ MORE >

Meditation linked to ‘real, lasting benefits’ for high-risk heart patients

A popular meditation technique may help high-risk patients protect their hearts for up to 10 years, according to a new randomized controlled trial published in Frontiers in Medicine.

READ MORE >
meditation yoga relax
Share on Twitter Share on Facebook Share on Linkedin

Meditation linked to ‘real, lasting benefits’ for high-risk heart patients

Share on Twitter Share on Facebook Share on Linkedin
meditation yoga relax
A popular meditation technique may help high-risk patients protect their hearts for up to 10 years, according to a new randomized controlled trial published in Frontiers in Medicine.
READ MORE >

Cuffless blood pressure measurement devices: Convenient, but not ready for clinical use

Cuffless BP measurements could potentially provide significant value for clinicians and patients alike. It is still too early, however, for these technologies to be used in a clinical setting; too many unanswered questions remain.

READ MORE >
The KardiaBand device from AliveCor is a more reliable tool for identifying atrial fibrillation (AFib) than the Apple Watch 4, according to a new head-to-head analysis published in JACC: Clinical Electrophysiology.
Share on Twitter Share on Facebook Share on Linkedin

Cuffless blood pressure measurement devices: Convenient, but not ready for clinical use

Share on Twitter Share on Facebook Share on Linkedin
The KardiaBand device from AliveCor is a more reliable tool for identifying atrial fibrillation (AFib) than the Apple Watch 4, according to a new head-to-head analysis published in JACC: Clinical Electrophysiology.
Cuffless BP measurements could potentially provide significant value for clinicians and patients alike. It is still too early, however, for these technologies to be used in a clinical setting; too many unanswered questions remain.
READ MORE >

Heart patients, stroke survivors may live longer if they stay active after hospital discharge

Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.

READ MORE >
walk exercise support family
Share on Twitter Share on Facebook Share on Linkedin

Heart patients, stroke survivors may live longer if they stay active after hospital discharge

Share on Twitter Share on Facebook Share on Linkedin
walk exercise support family
Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.
READ MORE >

The average wait time to see a cardiologist is now more than a month

To be exact, the average weight time for a cardiologist appointment in U.S. cities is 32.7 days. This is a 23% increase compared to 2022 and a 74% increase compared to 2004.

READ MORE >
Patients in waiting room.
Share on Twitter Share on Facebook Share on Linkedin

The average wait time to see a cardiologist is now more than a month

Share on Twitter Share on Facebook Share on Linkedin
Patients in waiting room.
To be exact, the average weight time for a cardiologist appointment in U.S. cities is 32.7 days. This is a 23% increase compared to 2022 and a 74% increase compared to 2004.
READ MORE >

Abbott's FreeStyle Libre helps patients with diabetes stay out of the hospital

New data out of Sweden show that using Abbott's continuous glucose monitor technology is associated with a reduced risk of being hospitalized for cardiac complications. This was true for patients with and without a history of prior heart disease.

READ MORE >
Abbott FreeStyle Libre 3 CGM
Share on Twitter Share on Facebook Share on Linkedin

Abbott's FreeStyle Libre helps patients with diabetes stay out of the hospital

Share on Twitter Share on Facebook Share on Linkedin
Abbott FreeStyle Libre 3 CGM
New data out of Sweden show that using Abbott's continuous glucose monitor technology is associated with a reduced risk of being hospitalized for cardiac complications. This was true for patients with and without a history of prior heart disease.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup